Nitric oxide (NO) production correlates with renal insufficiency and multiple organ dysfunction syndrome in severe sepsis

被引:43
作者
Groeneveld, PHP [1 ]
Kwappenberg, KMC [1 ]
Langermans, JAM [1 ]
Nibbering, PH [1 ]
Curtis, L [1 ]
机构
[1] BRITISH BIOTECHNOL LTD,CLIN RES & DEV,OXFORD OX4 5LY,ENGLAND
关键词
nitric oxide; nitrate; sepsis; pathogenesis; renal insufficiency; multiple organ dysfunction syndrome;
D O I
10.1007/BF01709336
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To investigate whether the production of nitric oxide (NO) relates to the development of renal insufficiency and multiple organ dysfunction syndrome (MODS) in patients with severe sepsis. Design: Prospective study in 23 patients with severe sepsis. Setting. Medical and surgical intensive care units (ICU) of three hospitals. Measurements and results. Serum nitrate levels, as an indirect parameter of the production of NO in vivo, and scores for renal insufficiency and MODS were determined in patients with severe sepsis during a 1-week period after admission to the ICU. The highest serum nitrate levels were found at 4 h (mean 52 +/- 16 mu mol/l) after entry into the study and the levels gradually declined thereafter. Patients with renal insufficiency had considerably higher serum nitrate levels during the study period than patients who did not develop renal insufficiency (MANOVA, p < 0.05). Serum nitrate levels correlated with scores for renal insufficiency (r = 0.60, p < 0.001), and far exceeded the levels that can be explained solely by reduced renal clearance of nitrate. Further analysis showed that serum nitrate levels significantly and positively correlated with scores for MODS (r = 0.44, p < 0.001). Conclusion: Our results indicate that the production of NO correlates with renal insufficiency and MODS in patients with severe sepsis and that this reactive nitrogen intermediate could be involved in the pathogenesis of organ failure in these critically ill patients.
引用
收藏
页码:1197 / 1202
页数:6
相关论文
共 40 条
  • [1] BERNARD GR, 1995, AM J RESP CRIT CARE, V151, pA323
  • [2] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [3] N(OMEGA)-AMINO-L-ARGININE, AN INHIBITOR OF NITRIC-OXIDE SYNTHASE, RAISES VASCULAR-RESISTANCE BUT INCREASES MORTALITY-RATES IN AWAKE CANINES CHALLENGED WITH ENDOTOXIN
    COBB, JP
    NATANSON, C
    HOFFMAN, WD
    LODATO, RF
    BANKS, S
    KOEV, CA
    SOLOMON, MA
    ELIN, RJ
    HOSSEINI, JM
    DANNER, RL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) : 1175 - 1182
  • [4] EVANS T, 1993, CIRC SHOCK, V41, P77
  • [5] L-ARGININE - NITRIC-OXIDE PATHWAY IN ENDOTOXEMIA AND HUMAN SEPTIC SHOCK
    GOMEZJIMENEZ, J
    SALGADO, A
    MOURELLE, M
    MARTIN, MC
    SEGURA, RM
    PERACAULA, R
    MONCADA, S
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (02) : 253 - 258
  • [6] GROENEVELD ABJ, 1986, SURGERY, V99, P140
  • [7] INCREASED PRODUCTION OF NITRIC-OXIDE IN PATIENTS INFECTED WITH THE EUROPEAN VARIANT OF HANTAVIRUS
    GROENEVELD, PHP
    COLSON, P
    KWAPPENBERG, KMC
    CLEMENT, J
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1995, 27 (05) : 453 - 456
  • [8] EFFECT OF NITRIC-OXIDE ON RENAL-FUNCTION IN SEPTIC SHOCK
    GROENEVELD, PHP
    RINGERS, J
    VANDISSEL, JT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (22) : 1620 - 1620
  • [9] NITRIC-OXIDE SYNTHESIS SERVES TO REDUCE HEPATIC DAMAGE DURING ACUTE MURINE ENDOTOXEMIA
    HARBRECHT, BG
    BILLIAR, TR
    STADLER, J
    DEMETRIS, AJ
    OCHOA, JB
    CURRAN, RD
    SIMMONS, RL
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (11) : 1568 - 1574
  • [10] EVIDENCE FOR CYTOKINE-INDUCIBLE NITRIC-OXIDE SYNTHESIS FROM L-ARGININE IN PATIENTS RECEIVING INTERLEUKIN-2 THERAPY
    HIBBS, JB
    WESTENFELDER, C
    TAINTOR, R
    VAVRIN, Z
    KABLITZ, C
    BARANOWSKI, RL
    WARD, JH
    MENLOVE, RL
    MCMURRY, MP
    KUSHNER, JP
    SAMLOWSKI, WE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) : 867 - 877